Katrina’s five-year delay in diagnosis was followed by a further wait for access to treatment.
- Treatments and side-effects
Category: Stories
Support for submission to MSAC for MRD testing reimbursement in ALL
- Acute lymphoblastic leukaemia
- Treatments and side-effects
First CAR T-cell trial for myeloma a success for Andrew
Andrew was the first person in Western Australia to have the life-changing therapy.
- Clinical trials
- Myeloma
- Treatments and side-effects
Ann’s finally in a happy place after 22 years living with myeloma
Ann Bruce shares the story of her diagnosis, in her own words.
- Myeloma
Diagnosed with leukaemia as a newborn
Zoe Li was a healthy baby when she was born, but five weeks later her parents were told the shocking news… she had leukaemia.
- Acute lymphoblastic leukaemia
MSAC advising on cilta-cel CAR T-cell therapy for myeloma
Ciltacabtagene autoleucel (cilta-cel), is being appraised by the Medical Services Advisory Committee (MSAC) for listing on the Medicare Benefits Schedule.
- Myeloma
Venetoclax moves us closer towards zero lives lost to blood cancer
- Advocacy and policy
- Research
Expert Series: Professor Andrew Perkins on MPN
It’s emerging in all cancers, but particularly in the MPNs, that “genomics is everything” according to Professor Andrew Perkins, an expert in myeloproliferative neoplasms (MPN).
- Interviews with experts
- Myeloproliferative neoplasms
- Research
Sharon’s 30 years living with MPN
Diagnosed with PV and ET at the age of 18, Sharon was having treatment when she fell pregnant with the first of her three healthy children in 2000.
- Myeloproliferative neoplasms
Expert Series: Dr Noemi Horvath on amyloidosis
Noemi Horvath is a highly reputed consultant haematologist at Royal Adelaide Hospital who has dedicated most of her life to her work and her special interest has long been amyloidosis.
- Amyloidosis
- Interviews with experts
